Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer

Includes bibliographical references (leaves 214-236).

Saved in:
Bibliographic Details
Main Author: MacLean, James Malcolm
Other Authors: Williamson, Anna-Lise
Format: Thesis
Language:English
Published: Division of Virology 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613150234279936
access_status_str Open Access
author MacLean, James Malcolm
author2 Williamson, Anna-Lise
author_browse MacLean, James Malcolm
Williamson, Anna-Lise
author_facet Williamson, Anna-Lise
MacLean, James Malcolm
author_sort MacLean, James Malcolm
collection Thesis
description Includes bibliographical references (leaves 214-236).
format Thesis
id oai:open.uct.ac.za:11427/2730
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:31:34.243Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2014
publishDateRange 2014
publishDateSort 2014
publisher Division of Virology
publisherStr Division of Virology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/2730 Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer MacLean, James Malcolm Williamson, Anna-Lise Medical Virology Includes bibliographical references (leaves 214-236). 2014-07-28T08:21:39Z 2014-07-28T08:21:39Z 2005 Doctoral Thesis Doctoral PhD http://hdl.handle.net/11427/2730 eng application/pdf Division of Virology Faculty of Health Sciences University of Cape Town
spellingShingle Medical Virology
MacLean, James Malcolm
Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
thesis_degree_str Doctoral
title Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
title_full Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
title_fullStr Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
title_full_unstemmed Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
title_short Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
title_sort investigation of the use of recombinant bcg expressing the major capsid protein li of human papillomavirus type 16 as a candidate vaccine for cervical cancer
topic Medical Virology
url http://hdl.handle.net/11427/2730
work_keys_str_mv AT macleanjamesmalcolm investigationoftheuseofrecombinantbcgexpressingthemajorcapsidproteinliofhumanpapillomavirustype16asacandidatevaccineforcervicalcancer